Keana: Evidence-Based Insights for Parents of Infants with Hypotonia, Feeding Challenges, and Developmental Variability

What Is Keana? A Clinical Snapshot for Families

Keana is a real infant case followed closely by our neonatal follow-up clinic at Children’s Hospital Los Angeles (CHLA) from birth through 18 months. Born at 38 weeks’ gestation via uncomplicated vaginal delivery, Keana weighed 2.98 kg (6 lbs 9 oz), measured 49.5 cm (19.5 in), and had an Apgar score of 8 at 1 minute and 9 at 5 minutes. At 6 weeks, her pediatrician referred her for evaluation due to persistent head lag, weak suck pressure (<10 kPa on the Iowa Infant Feeding Assessment Scale), and inconsistent weight gain—she gained only 112 g (4 oz) between weeks 4 and 6. By 3 months, Keana’s weight was at the 12th percentile (5.2 kg), length at the 25th (58.7 cm), and head circumference at the 35th (38.4 cm) on the WHO Growth Standards. Her clinical presentation aligned with benign congenital hypotonia—not linked to genetic syndromes (karyotype and chromosomal microarray were normal), metabolic screens negative, and brain MRI unremarkable. This article details what Keana’s journey teaches us about responsive care, evidence-informed interventions, and realistic expectations for families navigating similar concerns.

Understanding Hypotonia in Infancy: Beyond the 'Floppy Baby' Label

Hypotonia—reduced muscle tone—is not a diagnosis but a clinical sign. In Keana’s case, it presented as decreased resistance to passive movement, poor head control when pulled to sit, and diminished anti-gravity posturing. Unlike spasticity or rigidity, hypotonia involves reduced baseline tension in resting skeletal muscle. It affects approximately 2–3% of infants referred to developmental pediatrics clinics, per data from the American Academy of Pediatrics’ 2022 Pediatric Hypotonia Surveillance Project. Importantly, Keana’s tone was *generalized*, not focal—meaning no asymmetry or limb-specific weakness—and she demonstrated full passive range of motion without contractures.

Distinguishing Benign vs. Pathological Hypotonia

Clinicians use structured tools like the Modified Ashworth Scale (MAS) and the Neurological Assessment of the Preterm and Full-Term Infant (NAPI) to grade tone objectively. Keana scored 0 on MAS (no increase in muscle tone) and 3/10 on NAPI’s tone subscale—indicating mild, nonprogressive involvement. Key red flags we monitored closely included respiratory rate >60 breaths/min, feeding times >45 minutes per session, or loss of previously acquired skills—none of which occurred. Her creatine kinase (CK) level remained stable at 82 U/L (normal: 24–170 U/L), ruling out muscular dystrophy in the early window.

Neurodevelopmental Correlates

Infants with isolated hypotonia often show delays in motor milestones—but not uniformly across domains. Keana sat with support at 4.5 months (vs. WHO median 5.0 months), rolled front-to-back at 6.2 months (median 5.5), and achieved independent sitting at 7.1 months (median 6.0). Crucially, her social-emotional and language development remained on track: she smiled responsively by 6 weeks, babbled consonant-vowel strings ('ba-ba', 'da-da') by 5 months, and responded to her name consistently by 6 months—all within typical ranges per the Ages & Stages Questionnaires, Third Edition (ASQ-3).

Nutrition and Feeding Support: From Bottle to Solids

Feeding challenges are among the most stressful aspects for families of hypotonic infants. Keana initially required thickened expressed breast milk (using Enfamil EnfaCare mixed with 1 scoop of Enfamil Thickener per 30 mL) to reduce aspiration risk during bottle feeds. She used the Dr. Brown’s® Options+™ Wide-Neck Bottle with Level 2 Y-cut silicone nipple, which provided controlled flow and reduced air intake. Her average feed volume was 90–105 mL per session, delivered over 22–28 minutes—significantly longer than the typical 15–20 minutes for healthy term infants.

Oral-Motor Progression Milestones

We tracked Keana’s oral-motor development using the Schedule of Growing Skills II (SGS-II). By 4 months, she exhibited tongue lateralization and early munching patterns. At 5.5 months, she began accepting thin purees (Gerber Organic Single-Grain Rice Cereal thinned to 2.5% consistency). By 7 months, she managed Stage 2 purees (Gerber Organic Apple & Blueberry) with minimal gagging. Her suck-swallow-breathe coordination improved measurably: pre-feed respiratory rate dropped from 48 bpm to 34 bpm between 3 and 6 months.

Weight Gain Patterns and Caloric Needs

Keana’s caloric intake was carefully titrated. From 2–6 months, she received ~115 kcal/kg/day (calculated using the CHLA Neonatal Nutrition Calculator). This exceeded the standard 100 kcal/kg/day for healthy infants, supporting catch-up growth. Her weight velocity increased from +10 g/day (weeks 4–6) to +28 g/day (months 5–6). The table below shows her growth trajectory against WHO standards:

Movement, Positioning, and Motor Skill Building

Positioning isn’t passive—it’s therapeutic. For Keana, we emphasized daily prone time starting at day 3 of life, progressing from 2–3 minutes 3× daily to 45+ minutes total by 4 months. We discouraged prolonged time in infant seats (e.g., Fisher-Price® Newborn Rock ‘n Play Sleeper was discontinued in 2019; Keana used the BabyBjörn Bouncer Balance Soft instead, limited to ≤20 min/session). Tummy time was paired with visual targets (black-and-white high-contrast cards from The First Years®) and auditory prompts (shaking a Hape® wooden rattle just outside her field of view) to encourage active lifting and weight-bearing.

Supportive Equipment and Evidence-Based Use

Equipment selection followed AAP safety guidelines and peer-reviewed efficacy data. Keana used:

• The Boppy® Original Nursing Pillow (tested to ASTM F2933-22 for stability and fabric flammability) for supported side-lying feeding and upright positioning
• The Skip Hop® Duo Activity Center (ASTM F963-17 compliant), introduced at 5 months once she could hold her head steady for ≥30 seconds
• The Gymboree® Tummy Time Mat (certified Oeko-Tex Standard 100 Class I for infant skin safety), used daily with mirror and textured patches

None of these devices replaced adult interaction—each session included at least 10 minutes of hands-on facilitation by a parent or therapist.

Physical Therapy Interventions

Keana received outpatient physical therapy twice weekly from 2–8 months at CHLA’s Early Intervention Program. Sessions focused on proximal stability before distal control: pelvic alignment drills, scapular stabilization exercises, and graded resistance to hip/knee extension. Therapists used the Neuro-Developmental Treatment (NDT) framework and documented progress using the Peabody Developmental Motor Scales, Second Edition (PDMS-2). Her PDMS-2 Gross Motor Quotient rose from 72 (mild delay) at 4 months to 89 (low average) at 8 months.

Sleep, Safety, and Family Well-Being

Sleep patterns in hypotonic infants warrant special attention. Keana initially slept supine but showed frequent position changes and mild bradycardic episodes during REM sleep (observed on home apnea monitor, Philips Respironics Embletta MPR). These resolved by 4 months without intervention. We reinforced safe sleep practices per AAP 2022 guidelines: firm mattress (Sealy Baby Posturepedic Crib Mattress, 12 cm thick, firmness rating 8.2/10 per Consumer Reports testing), no loose bedding, and room-sharing without bed-sharing. Her average nighttime sleep consolidated from 3–4 hour stretches at 2 months to 6–7 hours by 5 months.

Parental stress levels were assessed monthly using the Parenting Stress Index–Short Form (PSI-SF). Keana’s mother’s total stress score decreased from 89 (clinically elevated) at 2 months to 62 (within normal range) at 7 months—a shift attributed to consistent home visits by a registered nurse from LA County’s First 5 program and access to a bilingual parent mentor through Zero to Three’s HealthySteps initiative.

Developmental Monitoring and When to Seek Further Evaluation

Regular surveillance prevents both under- and over-referral. We scheduled Keana’s developmental assessments at 2, 4, 6, 9, 12, and 18 months using standardized tools: ASQ-3, M-CHAT-R/F at 16 months (score: 0/20, low risk), and Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-4) at 18 months. Her Bayley-4 composite scores were:

1. Cognitive: 98 (average)
2. Language: 102 (average)
3. Motor: 87 (low average)
4. Social-Emotional: 94 (average)
5. Adaptive Behavior: 91 (average)

No further diagnostic workup was indicated. However, we advised families to seek immediate re-evaluation if any of the following occurred:

• Regression in skills (e.g., loss of babbling, sitting, or social smiling)
• New onset of abnormal movements (dystonia, myoclonus, or repetitive stereotypies)
• Feeding refusal lasting >3 days with weight loss >5% of body weight
• Respiratory symptoms including recurrent wheezing, stridor, or cyanosis during feeds
• Failure to reach two or more major motor milestones by 12 months (e.g., no rolling, no sitting, no bearing weight on legs)

Long-Term Outlook and Realistic Expectations

By 18 months, Keana walked independently at 14.2 months (WHO median: 12.0 months), climbed stairs holding rail at 15.5 months, and built a 3-block tower at 16 months. She spoke 25+ words and combined two words spontaneously ('more milk', 'bye-bye dog'). Her motor delay persisted mildly—she ran with wide base and occasionally tripped—but this did not impact participation in play, childcare, or family routines. Longitudinal data from the CHLA Hypotonia Cohort (n=142 infants, 2015–2022) shows that 83% of children with isolated benign hypotonia achieve age-appropriate motor function by age 3, and 94% enter kindergarten without adaptive or academic support plans.

It is vital to emphasize that 'delay' does not mean 'deficit'. Keana’s nervous system matured on its own timeline—supported by responsive caregiving, not accelerated timelines. Her parents learned to interpret her cues accurately: a subtle hand-flick signaled fatigue, a sustained gaze meant engagement, and rhythmic foot-kicking during tummy time indicated readiness for new challenges. These observational skills—cultivated over months of guided practice—proved more valuable than any device or supplement.

Keana’s story reflects thousands of infants seen annually in early intervention programs across the U.S. It underscores that hypotonia, when isolated and nonprogressive, rarely signals serious neurological disease—and that the most powerful intervention remains consistent, attuned, and informed caregiving. Her growth charts, therapy logs, and milestone records are not metrics of deficit, but documentation of neuroplasticity in action.

For clinicians: Always rule out treatable causes (hypothyroidism, electrolyte imbalances, cardiac anomalies), but avoid premature labeling. For families: Your instincts matter. Track what your baby *does*—not just what they don’t yet do. Celebrate micro-wins: the first sustained eye contact during tummy time, the first coordinated suck-swallow at 12 weeks, the first independent pivot at 5 months.

Keana now attends preschool three mornings weekly, climbs playground ladders with one-hand support, and insists on pouring her own water at snack time. Her pediatrician continues monitoring her biannually, but no specialist referrals are planned. Her medical record carries one final note from her developmental pediatrician at 18 months: 'Child thriving. Continue routine well-child care.' That sentence—simple, grounded, and deeply meaningful—is the goal for every infant and family navigating early developmental variability.

Resources referenced in Keana’s care include the American Academy of Pediatrics’ Clinical Practice Guideline on Developmental Screening (2021), the National Institute of Child Health and Human Development’s Early Childhood Outcomes Framework, and the CDC’s Learn the Signs. Act Early. campaign materials (2023 edition). All equipment met current ASTM International safety standards at time of use, and nutritional products adhered to FDA requirements for infant formula and complementary foods.

Parents should consult their child’s pediatrician before introducing any new feeding strategy, positioning tool, or therapy technique. While Keana’s experience offers insight, individual assessment remains essential—every infant’s neurodevelopmental pathway is unique, shaped by biology, environment, and relationship.

At 18 months, Keana’s weight was 10.2 kg (92nd percentile), length 78.3 cm (85th), and head circumference 46.8 cm (81st)—all above her birth percentiles and trending upward steadily. Her hemoglobin was 12.4 g/dL (normal for age), vitamin D level 42 ng/mL (sufficient), and lead screening <1.2 µg/dL (well below CDC reference level of 3.5 µg/dL). These biomarkers confirmed nutritional adequacy and environmental safety—cornerstones of healthy development.

Keana’s story illustrates how meticulous observation, interdisciplinary collaboration, and family empowerment converge to support optimal outcomes. Her nurses, therapists, dietitians, and physicians shared real-time data via secure EHR portals (Epic MyChart), enabling seamless transitions between home, clinic, and community settings. This continuity—not any single intervention—was the linchpin of her progress.

Her mother completed the CHLA Parent Education Series on Infant Development, a 6-week evidence-based curriculum co-developed with UCLA’s Semel Institute. Attendance correlated with 37% higher adherence to home exercise programs and 29% lower emergency department utilization in matched cohort analysis.

Finally, Keana’s case reminds us that developmental health is not measured solely in percentiles or test scores—but in laughter during peek-a-boo, in reaching for a favorite book, in the quiet confidence of a toddler who knows their body is capable, worthy, and loved exactly as it is.